Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial.

about

Macitentan in Pulmonary Arterial Hypertension: A Focus on Combination Therapy in the SERAPHIN Trial.

Item

http://www.wikidata.org/entity/Q47245549

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Macitentan in Pulmonary Arteri ...... Therapy in the SERAPHIN Trial.

@en

Macitentan in Pulmonary Arteri ...... Therapy in the SERAPHIN Trial.

@nl

type

Item

label

Macitentan in Pulmonary Arteri ...... Therapy in the SERAPHIN Trial.

@en

Macitentan in Pulmonary Arteri ...... Therapy in the SERAPHIN Trial.

@nl

prefLabel

Macitentan in Pulmonary Arteri ...... Therapy in the SERAPHIN Trial.

@en

Macitentan in Pulmonary Arteri ...... Therapy in the SERAPHIN Trial.

@nl

P1476

Macitentan in Pulmonary Arteri ...... Therapy in the SERAPHIN Trial.

@en

P2093

Pavel Jansa

http://www.w3.org/2001/XMLSchema#string

Tomás Pulido

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells

Beyond a single pathway: combination therapy in pulmonary arterial hypertension

Advances in therapeutic interventions for patients with pulmonary arterial hypertension

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

Riociguat for the treatment of pulmonary arterial hypertension.

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.

Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

The right ventricle in pulmonary hypertension.

P2888

s40256-017-0260-1

P304

1-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40256-017-0260-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29280064

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary hypertension

amide

mechanism of action

P932

5772137

http://www.w3.org/2001/XMLSchema#string